Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase

Experimental Dermatology

Volumn 22, Issue 2, 2013, Pages 125-130

  España, Agustín ^a   Mòdol, Teresa ^a   Gil, Maria P ^a   López Zabalza, Maria J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Acantholysis; Cantholysis; Immunoglobuline G; Mouse model; Nitric oxide synthase; Pemphigus vulgaris

Indexed keywords

CASPASE 3; CASPASE 9; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; MAMMALIAN TARGET OF RAPAMYCIN; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN BAX; PROTEIN BCL 2; STEROID RECEPTOR COACTIVATOR 1;

ACANTHOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; MOUSE; NONHUMAN; PEMPHIGUS VULGARIS; PEMPHIGUS VULGARIS ACANTHOLYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ACANTHOLYSIS; ANIMALS; BIOPSY; CASPASE 3; CASPASE 9; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE I; PEMPHIGUS; SRC-FAMILY KINASES; TIME FACTORS; TOR SERINE-THREONINE KINASES;

EID: 84873183133     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12088     Document Type: Article

References (49)

1. Stanley J R. J Clin Invest 1989: 83: 1443-1448.
2. Chernyavsky A I, Arredondo J, Kitajima Y et al. J Biol Chem 2007: 282: 13804-13812.
3. Nguyen V T, Ndoyen A, Shultz L D et al. J Clin Invest 2000: 106: 1467-1479.
4. Marchenko S, Chernyavsky A I, Arredondo J et al. J Biol Chem 2010: 285: 3695-3704.
5. Sitaru C, Zillikens D. Exp Dermatol 2005: 14: 861-875.
6. Grando S A. Autoimmunity 2012: 45: 7-35.
7. Esaki C, Seishima M, Yamada T et al. J Invest Dermatol 1995: 105: 329-333.
8. Seishima M, Esaki C, Osada K et al. J Invest Dermatol 1995: 104: 33-37.
9. Sánchez-Carpintero I, España A, Pelacho B et al. Br J Dermatol 2004: 151: 565-570.
10. Berkowitz P, Hu P, Liu Z et al. J Biol Chem 2005: 280: 23778-23784.
11. Pretel M, España A, Marquina M et al. Exp Dermatol 2009: 18: 771-780.
12. Waschke J, Spinder V, Bruggerman P et al. J Cell Biol 2006: 175: 721-727.
13. Gliem M, Heupel W M, Spindler V et al. Am J Physiol Cell Physiol 2010: 299: C606-C613.
14. Bystryn J C, Grando S A. J Am Acad Dermatol 2006: 54: 513-516.
15. Pelacho B, Natal C, España A et al. FEBS Lett 2004: 566: 6-10.
16. Gil M P, Modol T, España A et al. Exp Dermatol 2012: 21: 254-259.
17. Abramson S B, Amin A R, Clancy R M et al. Best Pract Res Clin Rheumatol 2001: 15: 831-845.
18. Alderton W K, Cooper C E, Knowles R G. Biochem J 2001: 357: 593-615.
19. Lyons C R. Adv Immunol 1995: 60: 323-371.
20. Nakai K, Shigemoto F, Yamamoto A et al. J Dermatol Sci 2003: 31: 211-218.
21. Schwentker A, Vodovotz Y, Weller R et al. Nitric Oxide 2002: 7: 1-10.
22. Romero-Graillet C, Aberdam E, Clement M et al. J Clin Invest 1997: 99: 635-642.
23. Bruch-Gerharz D, Fehsel K, Suschek C et al. J Exp Med 1996: 184: 2007-2012.
24. Becherel P A, Chosidow O, Le Goff L et al. Mol Med 1997: 3: 686-694.
25. Rowe A, Farrele A M, Bunker C B. Br J Dermatol 1997: 136: 18-23.
26. Hogg N, Darley-Usmar V M, Wison M T et al. Biochem J 1992: 281(part 2): 419-424.
27. Ischiropoulos H. Arch Biochem Biophys 1998: 1: 1-11.
28. Marquina M, España A, Fernández-Galar M et al. Br J Dermatol 2008: 159: 68-76.
29. Boissel J P, Ohly D, Bros M et al. J Invest Dermatol 2004: 123: 132-139.
30. Amagai M, Tsunoda K, Zillikens D et al. J Am Acad Dermatol 1999: 40: 167-170.
31. Bradford M M. Anal Biochem 1976: 72: 248-254.
32. Laemmli U K. Nature 1970: 227: 680-685.
33. Cirillo N, Cozzani E, Carrozzo M et al. Oral Dis 2012: 18: 442-458.
34. Liu L, Chen L, Chung J et al. Oncogene 2008: 27: 4998-5010.
35. Frusic-Zlotkin M, Raichenberg D, Wang X et al. Autoimmunity 2006: 39: 563-575.
36. Puviani M, Marconi A, Cozzani E et al. J Invest Dermatol 2003: 120: 164-167.
37. Wang X, Bregegere F, Frusic-Zlotkin M et al. Apoptosis 2004: 9: 131-143.
38. Frusic-Zlotkin M, Pergamentz R, Michel B et al. Ann N Y Acad Sci 2005: 1050: 371-379.
39. Bektas M, Jolly P, Rubenstein D S. Dermatol Res Pract 2010: 2010: 456841.
40. Sun M, Zhao Y, Gu Y et al. Neurochem Int 2009: 54: 339-346.
41. Mishra O P, Delivoria-Papadopoulos M. Neurosci Lett 2010: 480: 35-39.
42. Zhu C, Wang X, Qiu L et al. J Neurochem 2004: 90: 462-471.
43. Numata T, Saito T, Maekawa K et al. Biochem Biophys Res Commun 2002: 297: 517-522.
44. Natal C, Modol M T, Osés-Prieto J A et al. Apoptosis 2008: 13: 1356-1367.
45. Brüne B, von Knethen A, Sandau K B. Cell Death Differ 1999: 6: 969-975.
46. Weiske J, Schöneberg T, Schrödr W et al. J Biol Chem 2001: 276: 41175-41181.
47. Dusek R L, Getsios S, Chen F et al. J Biol Chem 2006: 281: 3614-3624.
48. Lüthi A U, Martin S J. Cell Death Differ 2007: 14: 641-650.
49. Grando S A, Laquer V T, Le H M. J Am Acad Dermatol 2011: 65: 684-686.